[1]
S. C. Cecere, “Olaparib as maintenance treatment in relapsed platinum-sensitive BRCA mutated ovarian cancer: real world experience in two Italian cancer Centers:  ”, CBN, vol. 5, no. 1, pp. 25–30, Apr. 2017.